Efficacy and safety of CDP-choline, cerebrolysin, MLC601, and edaravone in recovery of patients with acute ischemic strokes: a meta-analysis

Aim: Stroke is the second most common cause of mortality and disability worldwide with ischemic strokes being the predominant type. The advent of neuroprotectants brought hope of improved outcomes and quality of life, but current guidelines, despite numerous trials, have no strong recommendation adv...

Full description

Bibliographic Details

Published in:	Exploration of Neuroprotective Therapy
Main Authors:	Shafiq Dexter B. Abou Zaki, Johnny K. Lokin
Format:	Article
Language:	English
Published:	Open Exploration Publishing Inc. 2023-10-01
Subjects:	ischemic stroke neuroprotectants cdp-choline cerebrolysin edaravone mlc601
Online Access:	https://www.explorationpub.com/Journals/ent/Article/100457